Search
for

    Research 8 of 19

    1. Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study The Laryngoscope · 2026
    2. EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS Revista Ibero-Americana de Humanidades, Ciências e Educação · 2026
    3. 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review Journal of Investigative Dermatology · 2026
    4. 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization Journal of the American Academy of Dermatology · 2026
    5. Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes Dermatology and Therapy · 2026
    6. Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data Pharmaceuticals · 2026
    7. GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling Science Progress · 2026
    8. Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review Brazilian Journal of Hair Health · 2025
    All research results →

    Community 1

    1. Very agressive protection / regrowth stack on steroids Community · 5 Jan 2026

    Learn

    — no results

    Try a deeper search in learn →